Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Product Surveillance, Postmarketing | 1 | 2020 | 189 | 0.72 | Why? |
| Health Plan Implementation | 1 | 2020 | 571 | 0.59 | Why? |
| Advisory Committees | 11 | 2021 | 1418 | 0.54 | Why? |
| Immunization | 6 | 2021 | 2019 | 0.50 | Why? |
| Hepatitis A Antibodies | 1 | 2011 | 18 | 0.47 | Why? |
| Hepatitis A Vaccines | 2 | 2011 | 52 | 0.46 | Why? |
| Hepatitis A | 2 | 2011 | 140 | 0.45 | Why? |
| Hepatitis B Antibodies | 1 | 2007 | 142 | 0.32 | Why? |
| Health Care Rationing | 4 | 2021 | 2558 | 0.30 | Why? |
| Hepatitis B Vaccines | 1 | 2007 | 245 | 0.29 | Why? |
| Immunization Programs | 4 | 2021 | 2006 | 0.24 | Why? |
| Drug Approval | 5 | 2021 | 1325 | 0.22 | Why? |
| Clinical Trials, Phase IV as Topic | 1 | 2020 | 75 | 0.22 | Why? |
| United States Food and Drug Administration | 4 | 2021 | 1276 | 0.22 | Why? |
| Immunization, Secondary | 1 | 2007 | 1649 | 0.19 | Why? |
| Hepatitis B | 1 | 2007 | 888 | 0.19 | Why? |
| Practice Guidelines as Topic | 7 | 2021 | 15421 | 0.18 | Why? |
| United States | 14 | 2021 | 46150 | 0.16 | Why? |
| Vaccination | 2 | 2020 | 19050 | 0.15 | Why? |
| Adverse Drug Reaction Reporting Systems | 4 | 2021 | 694 | 0.15 | Why? |
| Ethics, Medical | 1 | 2021 | 533 | 0.13 | Why? |
| Mexican Americans | 1 | 2011 | 13 | 0.12 | Why? |
| Nutrition Surveys | 1 | 2011 | 287 | 0.10 | Why? |
| Resource Allocation | 1 | 2021 | 1771 | 0.10 | Why? |
| Viral Vaccines | 2 | 2020 | 7560 | 0.09 | Why? |
| Alaska | 1 | 2007 | 100 | 0.09 | Why? |
| Thrombocytopenia | 1 | 2021 | 2093 | 0.09 | Why? |
| Public Health Surveillance | 1 | 2020 | 3129 | 0.08 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.08 | Why? |
| Hepatitis B Surface Antigens | 1 | 2007 | 305 | 0.07 | Why? |
| Influenza Vaccines | 1 | 2020 | 2941 | 0.07 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.06 | Why? |
| Safety-Based Drug Withdrawals | 1 | 2021 | 52 | 0.06 | Why? |
| Drug Labeling | 1 | 2021 | 65 | 0.05 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.05 | Why? |
| Immunization Schedule | 1 | 2007 | 1305 | 0.05 | Why? |
| Hepatitis B virus | 1 | 2007 | 882 | 0.05 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.04 | Why? |
| Humans | 15 | 2021 | 930598 | 0.04 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2021 | 782 | 0.04 | Why? |
| Endemic Diseases | 1 | 2020 | 480 | 0.04 | Why? |
| African Americans | 1 | 2011 | 3363 | 0.04 | Why? |
| Residential Facilities | 1 | 2020 | 443 | 0.04 | Why? |
| Seroepidemiologic Studies | 1 | 2011 | 10017 | 0.04 | Why? |
| Child | 3 | 2021 | 70012 | 0.03 | Why? |
| Adult | 6 | 2021 | 244371 | 0.03 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.03 | Why? |
| Age Factors | 1 | 2011 | 21039 | 0.03 | Why? |
| Health Equity | 1 | 2021 | 1223 | 0.02 | Why? |
| Social Determinants of Health | 1 | 2021 | 1757 | 0.02 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2007 | 17020 | 0.02 | Why? |
| Risk | 1 | 2021 | 5288 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.02 | Why? |
| Aged | 5 | 2021 | 215776 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Child, Preschool | 2 | 2007 | 36283 | 0.02 | Why? |
| Infant, Newborn | 1 | 2007 | 23105 | 0.02 | Why? |
| Emergencies | 1 | 2021 | 4095 | 0.02 | Why? |
| Health Status Disparities | 1 | 2021 | 4072 | 0.02 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Vaccines | 1 | 2020 | 3692 | 0.01 | Why? |
| Male | 3 | 2021 | 367725 | 0.01 | Why? |
| Female | 3 | 2021 | 380317 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2006 | 8495 | 0.01 | Why? |
| Incidence | 1 | 2006 | 25622 | 0.00 | Why? |
Bell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(72)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_